CN102309550A - Traditional Chinese medicinal aerosol for preventing and treating summer humidity disease and preparation method thereof - Google Patents
Traditional Chinese medicinal aerosol for preventing and treating summer humidity disease and preparation method thereof Download PDFInfo
- Publication number
- CN102309550A CN102309550A CN2010102184478A CN201010218447A CN102309550A CN 102309550 A CN102309550 A CN 102309550A CN 2010102184478 A CN2010102184478 A CN 2010102184478A CN 201010218447 A CN201010218447 A CN 201010218447A CN 102309550 A CN102309550 A CN 102309550A
- Authority
- CN
- China
- Prior art keywords
- filtrate
- traditional chinese
- chinese medicinal
- preventing
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 16
- 201000010099 disease Diseases 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000706 filtrate Substances 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims abstract description 9
- 239000000341 volatile oil Substances 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000003380 propellant Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims description 22
- 238000000605 extraction Methods 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 235000008216 herbs Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 229950005162 benexate Drugs 0.000 claims description 8
- IAXUQWSLRKIRFR-SAABIXHNSA-N chembl2104696 Chemical compound C1C[C@@H](CNC(=N)N)CC[C@@H]1C(=O)OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IAXUQWSLRKIRFR-SAABIXHNSA-N 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 102000011759 adducin Human genes 0.000 claims description 2
- 108010076723 adducin Proteins 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 230000008673 vomiting Effects 0.000 abstract description 8
- 206010047700 Vomiting Diseases 0.000 abstract description 5
- 210000004916 vomit Anatomy 0.000 abstract description 3
- 206010012735 Diarrhoea Diseases 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 2
- 229940116229 borneol Drugs 0.000 abstract 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 208000004998 Abdominal Pain Diseases 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 206010028813 Nausea Diseases 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 238000005253 cladding Methods 0.000 abstract 1
- 208000002173 dizziness Diseases 0.000 abstract 1
- 230000008693 nausea Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 abstract 1
- 206010019345 Heat stroke Diseases 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 7
- 241000272201 Columbiformes Species 0.000 description 5
- 229910000365 copper sulfate Inorganic materials 0.000 description 5
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 3
- 229960004756 ethanol Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010579 first pass effect Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- AKUVRZKNLXYTJX-UHFFFAOYSA-N 3-benzylazetidine Chemical group C=1C=CC=CC=1CC1CNC1 AKUVRZKNLXYTJX-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010009192 Circulatory collapse Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 229960000794 baclofen Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001657 chlorpromazine hydrochloride Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 229960004127 naloxone Drugs 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- WRLGYAWRGXKSKG-UHFFFAOYSA-M phenobarbital sodium Chemical compound [Na+].C=1C=CC=CC=1C1(CC)C(=O)NC([O-])=NC1=O WRLGYAWRGXKSKG-UHFFFAOYSA-M 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal aerosol for preventing and treating a summer humidity disease and a preparation method thereof. The traditional Chinese medicinal aerosol comprises 150 to 250g of cablin potchouli herb, 150 to 250g of cassia bark, 150 to 250g of clove, 150 to 250g of costustoot, 60 to 120g of dahurian angelica root, 100 to 200g of liquoric root and 5 to 30g of borneol. The preparation method comprises the following steps of: extracting volatile components from the traditional Chinese medicinal materials in a supercritical CO2 extractor for later use, decocting medicinal dregs and the liquoric root in water for two times, respectively filtering the decoctions, and combining the filtrate; concentrating the mixed filtrate into clear paste of which the relative density at the temperature of 50 to 80 DEG C is 1.20 to 1.30, and cooling the clear paste; adding 95 percent of ethanol into the mixed filtrate until the alcohol content of the filtrate is up to 50 to 70 percent, stirring the filtrate, standing the filtrate for 24 hours, and filtering the filtrate to obtain a filtrate; cladding volatile oil with hydroxypropyl-beta-cyclodextrin, combining the clathrate and alcohol precipitated liquid, and filtering the mixture; and adding the borneol which is dissolved in ethanol into the mixture, uniformly mixing, and adding a propellant into the mixture to form the traditional Chinese medicinal aerosol. The traditional Chinese medicinal aerosol has the effects of causing resuscitation and restoring consciousness, clearing away heat and toxic material, removing dampness by means of aromatics, and relieving vomiting, is used for preventing and treating symptoms, such as dizzy, nausea and vomit, neurolysis, abdominal pain and diarrhoea, and the like, which are caused by a hyperpyretic summer humidity environment, can quickly take effect, and is more convenient to carry and orally take.
Description
Technical field
The present invention relates to a kind of Chinese Traditional Medicines compositions, relate to a kind of diseases induced medicinal herbs aerosol inhalation agent of hyperpyrexia heat-damp in summer environment and preparation method thereof that is used in the hot environment preventing and treating in summer specifically.
Background technology
In summer sultry, the moist environment, when human-body radiating is not smooth, can produce various diseases.Explain from the physiology; Human body heat production and heat radiation; Mainly keep dynamic equilibrium through hypothalamic thermoregulation heatstroke control, when outside air temperature surpasses skin temperature (32～35 ℃), body can not be heated from the external world with conduction, convection current and radiation mode heat radiation; At this moment, the perspiration evaporation becomes the unique channel that body distributes body heat.Under hot and humid environment, because evaporative heat loss is obstructed, be prone to the imbalance of primosome thermal balance, water, salt metabolism disorder, the acute febrile illness of crossing such as circulatory failure, brain tissue impairment.
Particularly acute heatstroke disease is a disease in the most common a kind of summer.Heatstroke is commonly called as sun stroke, and it is under daylight, to tan by the sun for a long time summer, or under other hot environments, works, and the giddy that is produced, dim eyesight, symptom such as nervous serious can also cause fervescence, faint or spasm.It medically is a kind of thermic disease, is divided into Three Estate usually, premonitory heatstroke, clear degree heatstroke and severe heatstroke.In when, premonitory heatstroke taking place and degree being suffered heatstroke clearly when, adopt physiotherapy usually, the patient that is about to suffer heatstroke is transferred to the shady and cool ventilation place rapidly and has a rest, and is coated with the expelling summer-heat medicine outward, Ru Rendan, rheocamphoradin etc.But, when stating the physics expelling summer-heat on the implementation, also to as early as possible the patient be sent to hospital to reduce the probability that other complication take place for the patient of severe heatstroke.
The Chinese medicine function ratio of common prevention summer-heat is more single, and is irritated in some comas for other, and the stomachache etc. of having loose bowels does not have therapeutical effect; And; The anti-summer-heat medicines of Western medicine such as normally used chlorpromazine, naloxone, baclofen all have the side effect on the degree not; These medicines with intramuscular injection or the administration of intravenous injection mode, are taken inconvenience mostly, and mostly most of Chinese patent medicine is oral formulations or tablet; Onset is slow, take and carry inconvenience, the part medicine also has bigger stimulation, patient to be difficult for accepting to digestive tract, is not suitable for first aid.Cause the needs of the organ injury of multisystems such as central nervous system, blood circulation to heatstroke, and have the single effect of medicine and use inconvenient defective, the present invention has developed Chinese medicine pharmaceutical preparation and the dosage form of using under the suitable hyperpyrexia heat-damp in summer environment thereof.
Aerosol is meant that medicinal substances extract or medical material fine powder and suitable propellant are enclosed in the withstand voltage hermetic container of special valve system, by the pressure of propellant content is the preparation of fine mist or the ejection of other forms during use.The medicinal herbs aerosol inhalation agent is meant with the Chinese medical theory to be foundation, according to the Chinese medicine combination principle, uses the Chinese medicine novel form that modern preparation technique is processed.The characteristics of medicinal herbs aerosol inhalation agent are: effectively avoid the first pass effect of oral administration, can directly reach site of action, and dispersion of medicine, infiltration rate is fast, has strengthened curative effect, has reduced the distribution of medicine at its hetero-organization, thereby has reduced side effect.Therefore for the treatment of upper respiratory diseases such as heatstroke, aerosol drug delivery has therapeutic index height, the little characteristics of side effect; Therefore, if on the form of Chinese drug of control high temperature summer-heat, adopt aerosol-type will effectively improve the curative effect of Chinese medicine preparation.
Summary of the invention
To the objective of the invention is that a kind of evident in efficacy, effect is rapid, easy to carry to prevent and treat medicinal herbs aerosol inhalation agent of heat-damp in summer disease and preparation method thereof in order providing,, to satisfy the army and the people's needs to overcome the above-mentioned defective that prior art exists.
The technical scheme of the present invention that realizes above-mentioned purpose does, a kind of medicinal herbs aerosol inhalation agent that prevents and treats the heat-damp in summer disease, and the mass number for preparing every 1000ml medicinal liquid needed raw material medicine is: Herba Pogostemonis 150～250g; Cortex Cinnamomi 150～250g; Flos Caryophylli 150～250g, the Radix Aucklandiae 150～250g, the Radix Angelicae Dahuricae 60～120g; Radix Glycyrrhizae 100～200g, Borneolum Syntheticum 5～30g.
The method that above-mentioned preparation prevents and treats the medicinal herbs aerosol inhalation agent of heat-damp in summer disease may further comprise the steps:
(1) get Herba Pogostemonis 150～250g, the Radix Aucklandiae 150～250g, Flos Caryophylli 150～250g, Cortex Cinnamomi 150～250g and the Radix Angelicae Dahuricae 60～120g, mix homogeneously is ground into coarse powder, puts supercritical CO
2The volatile oil part of its volatile ingredient part of abstraction instrument extraction is subsequent use;
(2) with (1) step medicinal residues and Radix Glycyrrhizae 100～200g add 10 times of quality decocting in water and carry 1～3 time, filtration, merging filtrate, filtrate decompression is concentrated into the clear paste of 60 ℃ of relative densities 1.2～1.3, puts cold;
(3) in (2) clear paste in step, add 95% ethanol and make it contain the alcohol amount to reach 50%～70%, stir, left standstill 24 hours, filter, alcohol deposit fluid;
(4) learn from else's experience (1) step supercritical CO
2Volatile oil part after the extraction is mixed with the HP-saturated aqueous solution, stirs 3～5 hours at 40～60 ℃, leaves standstill 24 hours, and the mixed liquor concentrating under reduced pressure is drying to obtain Benexate Hydrochloride;
(5) get Benexate Hydrochloride and Borneolum Syntheticum that alcohol deposit fluid, (4) step that (3) step makes makes, add solubilizing agent and emulsifying agent, mixing leaves standstill, and filters, and fill is poured propellant or medicinal liquid is sub-packed in the withstand voltage automiser spray of band valve after sealing.Solubilizing agent and emulsifying agent are respectively volumetric concentration 95% alcoholic solution and tween 80.
Supercritical CO in the above-mentioned steps (1)
2Adopt the separating and extracting method during extraction twice, extracting pressure 30MPa, 45 ℃ of extraction temperature are separated I and are separated II pressure and be 5MPa, the separation I with separate the II temperature and be respectively 45 ℃ and 35 ℃, extraction time is 2h.
The advantage that the present invention has is: (1) preparation of the present invention has the effect of quick treatment to the heatstroke of high temperature heat-damp in summer property; (2) aerosol-type has quick-acting and positioning action, can arrive medicine-feeding part fast, and can avoid the destruction of pipe intestinal digesting enzyme and the first pass effect of liver; (3) medicine is enclosed within the container, can keep the medicine cleaning, can increase stability of drug; (4) easy to use, can accurately control dosage by quantitative valve, guarantee that dosage is accurate; (5) drug dose is little, can reduce the untoward reaction of this medicine.
The specific embodiment
Below in conjunction with concrete embodiment and experiment effect technical scheme of the present invention is described:
Embodiment 1
Get Herba Pogostemonis 150～250g, Cortex Cinnamomi 150～250g, Flos Caryophylli 150～250g, the Radix Aucklandiae 150～250g, the Radix Angelicae Dahuricae 60～120g, mix homogeneously is ground into coarse powder, puts supercritical CO
2Its volatile ingredient part of abstraction instrument extraction, the volatile oil part is subsequent use; Medicinal residues and Radix Glycyrrhizae 100～200g add 10 times of water gagings and boil and carry 2 times, filter, and merging filtrate, filtrate decompression is concentrated into the clear paste of 60 ℃ of relative densities 1.2～1.3, puts cold.The ethanol of adding 95% makes the alcohol amount that contains of filtrating reach 50%～70%, stirs, and leaves standstill 24 hours, filters, and gets alcohol deposit fluid.
The supercritical CO of learning from else's experience
2Extract after the extraction is dissolved in isopyknic dehydrated alcohol, splashes into then in the HP-saturated aqueous solution of 10 times of amount volatile oil weight, stirs 3～5 hours in 40～60 ℃.Left standstill 24 hours, the mixed liquor concentrating under reduced pressure, drying, dry good Benexate Hydrochloride places exsiccator subsequent use.
Get above-mentioned alcohol deposit fluid, Benexate Hydrochloride, Borneolum Syntheticum, add an amount of solubilizing agent, for example 95% alcoholic solution and emulsifying agent, tween 80; Mixing leaves standstill, and filters fill; Seal, pour propellant and be sub-packed in the withstand voltage automiser spray of band valve in right amount or with medicinal liquid, promptly get.
Embodiment 2
Get Herba Pogostemonis 178g, Cortex Cinnamomi 178g, Flos Caryophylli 178g, Radix Aucklandiae 178g, Radix Angelicae Dahuricae 88g, Radix Glycyrrhizae 120g, Borneolum Syntheticum 25g.Mix homogeneously is ground into coarse powder, puts supercritical CO
2Its volatile ingredient part of abstraction instrument extraction, the volatile oil part is subsequent use; Medicinal residues and Radix Glycyrrhizae 120g add 10 times of water gagings and boil and carry 2 times, filter, and merging filtrate, filtrate decompression is concentrated into the clear paste of 60 ℃ of relative densities 1.2～1.3, puts cold.The ethanol of adding 95% makes the alcohol amount that contains of filtrating reach 60%, stirs, and leaves standstill 24 hours, filters, and gets alcohol deposit fluid.
The supercritical CO of learning from else's experience
2Extract after the extraction is dissolved in isopyknic dehydrated alcohol, splashes into then in the HP-saturated aqueous solution of 10 times of amount volatile oil weight, stirs 4 hours in 40～60 ℃.Left standstill 24 hours, the mixed liquor concentrating under reduced pressure, drying, dry good Benexate Hydrochloride places exsiccator subsequent use.
Get above-mentioned alcohol deposit fluid, Benexate Hydrochloride, Borneolum Syntheticum, add an amount of solubilizing agent, like 95% alcoholic solution and emulsifying agent, like tween 80; Mixing leaves standstill, and filters fill; Seal, pour propellant and be sub-packed in the withstand voltage automiser spray of band valve in right amount or with medicinal liquid, promptly get.
Utilize the experiment effect of medicinal herbs aerosol inhalation agent on animal body of preventing and treating the heat-damp in summer disease of step preparation of the foregoing description 1 and embodiment 2 following:
1, to causing the mouse anti convulsions test that frightened agent is brought out
Aerosol adopts the aerosol of the production technology production of pressing embodiment 2.Get above-mentioned aerosol, matched group is powder group and that group of phenobarbital.
Adopt the peaceful convulsions experimental technique in mice scholar ground; Result such as table 1, the result shows that the middle and high dose groups of aerosol (5.78g/kg, 11.57g/kg) can significantly reduce the mice convulsion incidence rate, and obviously prolongs the incubation period of mice against seizure; Prolong the death time of convulsions mice; Reduce mortality rate (P＜0.05 or P＜0.01), effect is better than the March Powder experimental group, but is weaker than the sodium phenobarbital experimental group.
Table 1 shows the anticonvulsant action of aerosol
Compare with the blank group,
*P＜0.05,
*P＜0.01
2, aerosol causes the influence of pigeon vomiting model to copper sulfate
Adopt copper sulfate to cause pigeon vomiting experimental technique, observe aerosol copper sulfate is caused the influence that pigeon vomits, like table 2
Table 2 aerosol causes the influence of pigeon vomiting to copper sulfate.
Compare with the blank group,
*P＜0.05,
*P＜0.01
The result shows: the basic, normal, high dose groups of aerosol all can obviously reduce the number of times of pigeon vomiting due to the copper sulfate; Prolong it and vomit incubation period; High dose group with give repeated exhortations the matched group there was no significant difference, diffusing then obviously be weaker than aerosol, point out this medicine to have intensive town to tell effect.
3, aerosol is to the influence of mice high temperature heatstroke model
Under high temperature (43 ℃), high humidity (relative humidity 70%) condition; Aerosol is to the influence of mice heatstroke model; The result shows that high dose group in the administration (5.78g/kg, 11.57g/kg) and positive controls (chlorpromazine hydrochloride group) can obviously reduce mice anus temperature climbing speed and mortality rate, can prolong the time-to-live (P＜0.05 or P＜0.01).
The result shows that aerosol has anti-heatstroke effect.
4, aerosol is to 2, the influence of rat fever due to the 2, 4-dinitrophenol
Adopt 2, rat fever experimental technique due to the 2, 4-dinitrophenol is observed aerosol to 2, the influence of rat fever due to the 2, 4-dinitrophenol.Experimental result shows: to 2,2, 4-dinitrophenol pyrogenicity has the effect of cooling, and aspirin group and high dose group are compared with the blank group and had significant difference, shows that aerosol has certain refrigeration function.
Technique scheme has only embodied the optimal technical scheme of technical scheme of the present invention, the technical staff in present technique field to some part wherein some changes that possibly make all embodied principle of the present invention, belong within protection scope of the present invention.
Claims (4)
1. a medicinal herbs aerosol inhalation agent that prevents and treats the heat-damp in summer disease is characterized in that, the mass number for preparing every 1000ml medicinal liquid needed raw material medicine is: Herba Pogostemonis 150～250g; Cortex Cinnamomi 150～250g, Flos Caryophylli 150～250g, the Radix Aucklandiae 150～250g; The Radix Angelicae Dahuricae 60～120g, Radix Glycyrrhizae 100～200g, Borneolum Syntheticum 5～30g.
2. method for preparing of preventing and treating the medicinal herbs aerosol inhalation agent of heat-damp in summer disease is characterized in that this method may further comprise the steps:
(1) get Herba Pogostemonis 150～250g, the Radix Aucklandiae 150～250g, Flos Caryophylli 150～250g, Cortex Cinnamomi 150～250g and the Radix Angelicae Dahuricae 60～120g, mix homogeneously is ground into coarse powder, puts supercritical CO
2The volatile oil part of its volatile ingredient part of abstraction instrument extraction is subsequent use;
(2) with (1) step medicinal residues and Radix Glycyrrhizae 100～200g add 10 times of quality decocting in water and carry 1～3 time, filtration, merging filtrate, filtrate decompression is concentrated into the clear paste of 60 ℃ of relative densities 1.2～1.3, puts cold;
(3) in (2) clear paste in step, add 95% ethanol and make it contain the alcohol amount to reach 50%～70%, stir, left standstill 24 hours, filter, alcohol deposit fluid;
(4) learn from else's experience (1) step supercritical CO
2Volatile oil part after the extraction is mixed with the HP-saturated aqueous solution, stirs 3～5 hours at 40～60 ℃, leaves standstill 24 hours, and the mixed liquor concentrating under reduced pressure is drying to obtain Benexate Hydrochloride;
(5) get Benexate Hydrochloride and Borneolum Syntheticum that alcohol deposit fluid, (4) step that (3) step makes makes, add solubilizing agent and emulsifying agent, mixing leaves standstill, and filters, and fill is poured propellant or medicinal liquid is sub-packed in the withstand voltage automiser spray of band valve after sealing.
3. method for preparing of preventing and treating the medicinal herbs aerosol inhalation agent of heat-damp in summer disease according to claim 2 is characterized in that, the supercritical CO in (1) step
2Adopt the separating and extracting method during extraction twice, extracting pressure 30MPa, 45 ℃ of extraction temperature are separated I and are separated II pressure and be 5MPa, the separation I with separate the II temperature and be respectively 45 ℃ and 35 ℃, extraction time is 2h.
4. method for preparing of preventing and treating the medicinal herbs aerosol inhalation agent of heat-damp in summer disease according to claim 2 is characterized in that solubilizing agent in the step (5) and emulsifying agent are respectively volumetric concentration 95% alcoholic solution and tween 80.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102184478A CN102309550A (en) | 2010-07-06 | 2010-07-06 | Traditional Chinese medicinal aerosol for preventing and treating summer humidity disease and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102184478A CN102309550A (en) | 2010-07-06 | 2010-07-06 | Traditional Chinese medicinal aerosol for preventing and treating summer humidity disease and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102309550A true CN102309550A (en) | 2012-01-11 |
Family
ID=45423358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102184478A Pending CN102309550A (en) | 2010-07-06 | 2010-07-06 | Traditional Chinese medicinal aerosol for preventing and treating summer humidity disease and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102309550A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107875280A (en) * | 2017-11-13 | 2018-04-06 | 青岛卓森纳生物工程有限公司 | A kind of Traditional Chinese medicinal aerosol for preventing and treating thermoplegia and preparation method thereof |
| CN110801461A (en) * | 2019-11-15 | 2020-02-18 | 健民药业集团股份有限公司 | Aerosol for treating eczema |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1169289A (en) * | 1996-07-02 | 1998-01-07 | 贾兴武 | Medicinal powder for preventing from seasonal febrile diseases |
| CN1368292A (en) * | 2001-02-06 | 2002-09-11 | 杨孟君 | Nano medicing 'Wenzhong Zhixie' and its preparing process |
| CN1444985A (en) * | 2003-03-18 | 2003-10-01 | 彭少明 | Oil for comforting channels and collaterals |
| CN101229355A (en) * | 2008-01-30 | 2008-07-30 | 苟于洋 | Rheumatism soup |
| CN101564501A (en) * | 2008-04-25 | 2009-10-28 | 北京和润创新医药科技发展有限公司 | Big activating collateral preparation and preparation method thereof |
| CN101637607A (en) * | 2009-08-25 | 2010-02-03 | 上海中华药业有限公司 | Dragon and tiger rentan plant medicine composition, preparation method and application thereof |
| CN102309549A (en) * | 2010-07-06 | 2012-01-11 | 中国人民解放军第三○二医院 | Traditional Chinese medicine for preventing and treating hyperpyretic summer humidity disease |
-
2010
- 2010-07-06 CN CN2010102184478A patent/CN102309550A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1169289A (en) * | 1996-07-02 | 1998-01-07 | 贾兴武 | Medicinal powder for preventing from seasonal febrile diseases |
| CN1368292A (en) * | 2001-02-06 | 2002-09-11 | 杨孟君 | Nano medicing 'Wenzhong Zhixie' and its preparing process |
| CN1444985A (en) * | 2003-03-18 | 2003-10-01 | 彭少明 | Oil for comforting channels and collaterals |
| CN101229355A (en) * | 2008-01-30 | 2008-07-30 | 苟于洋 | Rheumatism soup |
| CN101564501A (en) * | 2008-04-25 | 2009-10-28 | 北京和润创新医药科技发展有限公司 | Big activating collateral preparation and preparation method thereof |
| CN101637607A (en) * | 2009-08-25 | 2010-02-03 | 上海中华药业有限公司 | Dragon and tiger rentan plant medicine composition, preparation method and application thereof |
| CN102309549A (en) * | 2010-07-06 | 2012-01-11 | 中国人民解放军第三○二医院 | Traditional Chinese medicine for preventing and treating hyperpyretic summer humidity disease |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107875280A (en) * | 2017-11-13 | 2018-04-06 | 青岛卓森纳生物工程有限公司 | A kind of Traditional Chinese medicinal aerosol for preventing and treating thermoplegia and preparation method thereof |
| CN110801461A (en) * | 2019-11-15 | 2020-02-18 | 健民药业集团股份有限公司 | Aerosol for treating eczema |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742939A (en) | Medicine for treating pulmonary fibrosis and preparing method | |
| CN102058673B (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
| BR112015011699A2 (en) | herbal supplement and its uses and method for treating bloating, constipation and / or weight gain in a human subject | |
| CN105796654B (en) | Traditional Chinese medicine composition for treating diarrhea-predominant irritable bowel syndrome, navel patch and application | |
| CN103610795B (en) | A kind of preparation method of eucommia bark depressor oral formulations | |
| CN101032604A (en) | Chinese medicine preparation for curing vascular type headache | |
| CN102309550A (en) | Traditional Chinese medicinal aerosol for preventing and treating summer humidity disease and preparation method thereof | |
| CN1256120C (en) | Medicine for treating chronic pelvic inflammation and its preparing method | |
| CN105535495A (en) | Chinese medicinal composition for treating esophageal cancer by reinforcing vital essence and strengthening primordial qi and preparation method | |
| CN102406905B (en) | Medicinal composition for preventing or treating chronic atrophic gastritis and use thereof | |
| CN1260196A (en) | For mulation for analgesia smearing agent and its preparation technology | |
| CN101890062A (en) | Use of nardostachys chinensis batal and extract thereof in preparation of medicaments for treating gastric ulcer | |
| CN105727089A (en) | Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome | |
| CN105998752B (en) | A kind of Chinese medicine composition for the treatment of of vascular dementia | |
| CN105435196A (en) | Externally-applied traditional Chinese medicine ointment for treating qi stagnation and blood stasis coronary angina pectoris with chronic gastritis and preparation method thereof | |
| CN100486621C (en) | Chinese medicinal composition for treating hemilateral headache and its preparation method | |
| CN104337898B (en) | A kind of Chinese medicine composition of the treatment gout containing Semen Pruni | |
| CN111388604B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
| CN108186821A (en) | A kind of Chinese medicine composition for treating nervous headache and its preparation method and application | |
| CN112294915B (en) | Pharmaceutical composition for treating emphysema and preparation method thereof | |
| CN102579842B (en) | A kind of Chinese medicine composition for the treatment of Gilles de la Tourette's syndrome and preparation method thereof | |
| CN101991645A (en) | Preparation for treating coronary heart disease and preparation method thereof | |
| CN105663529A (en) | Traditional Chinese medicinal composition for treating depression and preparation method of traditional Chinese medicinal composition | |
| CN1853711A (en) | Xinmaikangzhong Chinese medicinal composition and preparation thereof | |
| CN104173808B (en) | A kind of Chinese medicine and preparation method thereof for treating flaming-up of the liverfire type hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120111 |